These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19177330)

  • 1. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs.
    Lehar C; Jayappa H; Erskine J; Brown A; Sweeney D; Wassmoen T
    Vet Ther; 2008; 9(4):257-62. PubMed ID: 19177330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough).
    Kontor EJ; Wegrzyn RJ; Goodnow RA
    Am J Vet Res; 1981 Oct; 42(10):1694-8. PubMed ID: 6275747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica.
    Iemura R; Tsukatani R; Micallef MJ; Taneno A
    Vet Rec; 2009 Dec; 165(25):747-51. PubMed ID: 20023279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica.
    Davis R; Jayappa H; Abdelmagid OY; Armstrong R; Sweeney D; Lehr C
    Vet Ther; 2007; 8(1):32-40. PubMed ID: 17447223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity.
    Chladek DW; Williams JM; Gerber DL; Harris LL; Murdock FM
    Am J Vet Res; 1981 Feb; 42(2):266-70. PubMed ID: 6266289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
    Larson LJ; Schultz RD
    Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs.
    Ellis JA; Haines DM; West KH; Burr JH; Dayton A; Townsend HG; Kanara EW; Konoby C; Crichlow A; Martin K; Headrick G
    J Am Vet Med Assoc; 2001 Feb; 218(3):367-75. PubMed ID: 11201562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs.
    Ellis JA; Krakowka GS; Dayton AD; Konoby C
    J Am Vet Med Assoc; 2002 Jan; 220(1):43-8. PubMed ID: 12680446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus 2, Bordetella bronchiseptica, and Parainfluenza Molecular Diagnostic Assay Results in Puppies After vaccination with Modified Live Vaccines.
    Ruch-Gallie R; Moroff S; Lappin MR
    J Vet Intern Med; 2016; 30(1):164-6. PubMed ID: 26692461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal vaccination of dogs with liver avirulent Bordetella bronchiseptica: correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis.
    Bey RF; Shade FJ; Goodnow RA; Johnson RC
    Am J Vet Res; 1981 Jul; 42(7):1130-2. PubMed ID: 7271029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of intranasal and oral vaccines against Bordetella bronchiseptica in dogs.
    Ellis JA; Gow SP; Waldner CL; Shields S; Wappel S; Bowers A; Lacoste S; Xu Z; Ball E
    Vet J; 2016 Jun; 212():71-7. PubMed ID: 27256028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of intranasal and injectable vaccines in stimulating
    Ellis JA; Gow SP; Lee LB; Lacoste S; Ball EC
    Can Vet J; 2017 Aug; 58(8):809-815. PubMed ID: 28761185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine.
    McCandlish IA; Thompson H; Wright NG
    Res Vet Sci; 1978 Jul; 25(1):45-50. PubMed ID: 705048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccination of dogs with a monovalent live-avirulent vaccine confers 1 year of immunity against Bordetella bronchiseptica challenge.
    Hainer N; Velineni S; Bowers A; Waite C; Walker J; Wilmes L; Tague A; King V; Millership J; Martorell S
    Vet J; 2021 Dec; 278():105775. PubMed ID: 34800656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella bronchiseptica pneumonia in a kidney-pancreas transplant patient after exposure to recently vaccinated dogs.
    Gisel JJ; Brumble LM; Johnson MM
    Transpl Infect Dis; 2010 Feb; 12(1):73-6. PubMed ID: 19874567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against canine bordetellosis using an aluminum hydroxide adjuvant vaccine.
    McCandlish IA; Thompson H; Wright NG
    Res Vet Sci; 1978 Jul; 25(1):51-7. PubMed ID: 705049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.